Global Age-related Macular Degeneration Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 12-Jul-2021
No. of pages: 108
Inquire Before Buying

Market Analysis and Insights: Global Age-related Macular Degeneration Market

The global Age-related Macular Degeneration market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Age-related Macular Degeneration market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Age-related Macular Degeneration market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Age-related Macular Degeneration market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Age-related Macular Degeneration market.

Global Age-related Macular Degeneration Scope and Market Size

Age-related Macular Degeneration market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Age-related Macular Degeneration market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Wet AMD

- Dry AMD

Segment by Application

- Drugstore

- Hospital

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Bayer HealthCare

- F. Hoffmann-La Roche

- Novartis

- Regeneron Pharmaceuticals

- Alcon

- Allergan

- Avalanche

- Bausch+Lomb

- Gilead Sciences

- Iconic Therapeutics

- Neurotech Pharmaceuticals

- Ohr Pharmaceutical

Global Age-related Macular Degeneration Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Age-related Macular Degeneration Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Wet AMD
1.2.3 Dry AMD
1.3 Market by Application
1.3.1 Global Age-related Macular Degeneration Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Age-related Macular Degeneration Market Perspective (2016-2027)
2.2 Age-related Macular Degeneration Growth Trends by Regions
2.2.1 Age-related Macular Degeneration Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Age-related Macular Degeneration Historic Market Share by Regions (2016-2021)
2.2.3 Age-related Macular Degeneration Forecasted Market Size by Regions (2022-2027)
2.3 Age-related Macular Degeneration Industry Dynamic
2.3.1 Age-related Macular Degeneration Market Trends
2.3.2 Age-related Macular Degeneration Market Drivers
2.3.3 Age-related Macular Degeneration Market Challenges
2.3.4 Age-related Macular Degeneration Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Age-related Macular Degeneration Players by Revenue
3.1.1 Global Top Age-related Macular Degeneration Players by Revenue (2016-2021)
3.1.2 Global Age-related Macular Degeneration Revenue Market Share by Players (2016-2021)
3.2 Global Age-related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Age-related Macular Degeneration Revenue
3.4 Global Age-related Macular Degeneration Market Concentration Ratio
3.4.1 Global Age-related Macular Degeneration Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Age-related Macular Degeneration Revenue in 2020
3.5 Age-related Macular Degeneration Key Players Head office and Area Served
3.6 Key Players Age-related Macular Degeneration Product Solution and Service
3.7 Date of Enter into Age-related Macular Degeneration Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Age-related Macular Degeneration Breakdown Data by Type
4.1 Global Age-related Macular Degeneration Historic Market Size by Type (2016-2021)
4.2 Global Age-related Macular Degeneration Forecasted Market Size by Type (2022-2027)
5 Age-related Macular Degeneration Breakdown Data by Application
5.1 Global Age-related Macular Degeneration Historic Market Size by Application (2016-2021)
5.2 Global Age-related Macular Degeneration Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Age-related Macular Degeneration Market Size (2016-2027)
6.2 North America Age-related Macular Degeneration Market Size by Type
6.2.1 North America Age-related Macular Degeneration Market Size by Type (2016-2021)
6.2.2 North America Age-related Macular Degeneration Market Size by Type (2022-2027)
6.2.3 North America Age-related Macular Degeneration Market Size by Type (2016-2027)
6.3 North America Age-related Macular Degeneration Market Size by Application
6.3.1 North America Age-related Macular Degeneration Market Size by Application (2016-2021)
6.3.2 North America Age-related Macular Degeneration Market Size by Application (2022-2027)
6.3.3 North America Age-related Macular Degeneration Market Size by Application (2016-2027)
6.4 North America Age-related Macular Degeneration Market Size by Country
6.4.1 North America Age-related Macular Degeneration Market Size by Country (2016-2021)
6.4.2 North America Age-related Macular Degeneration Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Age-related Macular Degeneration Market Size (2016-2027)
7.2 Europe Age-related Macular Degeneration Market Size by Type
7.2.1 Europe Age-related Macular Degeneration Market Size by Type (2016-2021)
7.2.2 Europe Age-related Macular Degeneration Market Size by Type (2022-2027)
7.2.3 Europe Age-related Macular Degeneration Market Size by Type (2016-2027)
7.3 Europe Age-related Macular Degeneration Market Size by Application
7.3.1 Europe Age-related Macular Degeneration Market Size by Application (2016-2021)
7.3.2 Europe Age-related Macular Degeneration Market Size by Application (2022-2027)
7.3.3 Europe Age-related Macular Degeneration Market Size by Application (2016-2027)
7.4 Europe Age-related Macular Degeneration Market Size by Country
7.4.1 Europe Age-related Macular Degeneration Market Size by Country (2016-2021)
7.4.2 Europe Age-related Macular Degeneration Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Age-related Macular Degeneration Market Size (2016-2027)
8.2 Asia-Pacific Age-related Macular Degeneration Market Size by Type
8.2.1 Asia-Pacific Age-related Macular Degeneration Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Age-related Macular Degeneration Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Age-related Macular Degeneration Market Size by Type (2016-2027)
8.3 Asia-Pacific Age-related Macular Degeneration Market Size by Application
8.3.1 Asia-Pacific Age-related Macular Degeneration Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Age-related Macular Degeneration Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Age-related Macular Degeneration Market Size by Application (2016-2027)
8.4 Asia-Pacific Age-related Macular Degeneration Market Size by Region
8.4.1 Asia-Pacific Age-related Macular Degeneration Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Age-related Macular Degeneration Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Age-related Macular Degeneration Market Size (2016-2027)
9.2 Latin America Age-related Macular Degeneration Market Size by Type
9.2.1 Latin America Age-related Macular Degeneration Market Size by Type (2016-2021)
9.2.2 Latin America Age-related Macular Degeneration Market Size by Type (2022-2027)
9.2.3 Latin America Age-related Macular Degeneration Market Size by Type (2016-2027)
9.3 Latin America Age-related Macular Degeneration Market Size by Application
9.3.1 Latin America Age-related Macular Degeneration Market Size by Application (2016-2021)
9.3.2 Latin America Age-related Macular Degeneration Market Size by Application (2022-2027)
9.3.3 Latin America Age-related Macular Degeneration Market Size by Application (2016-2027)
9.4 Latin America Age-related Macular Degeneration Market Size by Country
9.4.1 Latin America Age-related Macular Degeneration Market Size by Country (2016-2021)
9.4.2 Latin America Age-related Macular Degeneration Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Age-related Macular Degeneration Market Size (2016-2027)
10.2 Middle East & Africa Age-related Macular Degeneration Market Size by Type
10.2.1 Middle East & Africa Age-related Macular Degeneration Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Age-related Macular Degeneration Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Age-related Macular Degeneration Market Size by Type (2016-2027)
10.3 Middle East & Africa Age-related Macular Degeneration Market Size by Application
10.3.1 Middle East & Africa Age-related Macular Degeneration Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Age-related Macular Degeneration Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Age-related Macular Degeneration Market Size by Application (2016-2027)
10.4 Middle East & Africa Age-related Macular Degeneration Market Size by Country
10.4.1 Middle East & Africa Age-related Macular Degeneration Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Age-related Macular Degeneration Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Company Details
11.1.2 Bayer HealthCare Business Overview
11.1.3 Bayer HealthCare Age-related Macular Degeneration Introduction
11.1.4 Bayer HealthCare Revenue in Age-related Macular Degeneration Business (2016-2021)
11.1.5 Bayer HealthCare Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Age-related Macular Degeneration Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Age-related Macular Degeneration Introduction
11.3.4 Novartis Revenue in Age-related Macular Degeneration Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Regeneron Pharmaceuticals
11.4.1 Regeneron Pharmaceuticals Company Details
11.4.2 Regeneron Pharmaceuticals Business Overview
11.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Introduction
11.4.4 Regeneron Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2016-2021)
11.4.5 Regeneron Pharmaceuticals Recent Development
11.5 Alcon
11.5.1 Alcon Company Details
11.5.2 Alcon Business Overview
11.5.3 Alcon Age-related Macular Degeneration Introduction
11.5.4 Alcon Revenue in Age-related Macular Degeneration Business (2016-2021)
11.5.5 Alcon Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview
11.6.3 Allergan Age-related Macular Degeneration Introduction
11.6.4 Allergan Revenue in Age-related Macular Degeneration Business (2016-2021)
11.6.5 Allergan Recent Development
11.7 Avalanche
11.7.1 Avalanche Company Details
11.7.2 Avalanche Business Overview
11.7.3 Avalanche Age-related Macular Degeneration Introduction
11.7.4 Avalanche Revenue in Age-related Macular Degeneration Business (2016-2021)
11.7.5 Avalanche Recent Development
11.8 Bausch+Lomb
11.8.1 Bausch+Lomb Company Details
11.8.2 Bausch+Lomb Business Overview
11.8.3 Bausch+Lomb Age-related Macular Degeneration Introduction
11.8.4 Bausch+Lomb Revenue in Age-related Macular Degeneration Business (2016-2021)
11.8.5 Bausch+Lomb Recent Development
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Details
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences Age-related Macular Degeneration Introduction
11.9.4 Gilead Sciences Revenue in Age-related Macular Degeneration Business (2016-2021)
11.9.5 Gilead Sciences Recent Development
11.10 Iconic Therapeutics
11.10.1 Iconic Therapeutics Company Details
11.10.2 Iconic Therapeutics Business Overview
11.10.3 Iconic Therapeutics Age-related Macular Degeneration Introduction
11.10.4 Iconic Therapeutics Revenue in Age-related Macular Degeneration Business (2016-2021)
11.10.5 Iconic Therapeutics Recent Development
11.11 Neurotech Pharmaceuticals
11.11.1 Neurotech Pharmaceuticals Company Details
11.11.2 Neurotech Pharmaceuticals Business Overview
11.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Introduction
11.11.4 Neurotech Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2016-2021)
11.11.5 Neurotech Pharmaceuticals Recent Development
11.12 Ohr Pharmaceutical
11.12.1 Ohr Pharmaceutical Company Details
11.12.2 Ohr Pharmaceutical Business Overview
11.12.3 Ohr Pharmaceutical Age-related Macular Degeneration Introduction
11.12.4 Ohr Pharmaceutical Revenue in Age-related Macular Degeneration Business (2016-2021)
11.12.5 Ohr Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Age-related Macular Degeneration Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Wet AMD
Table 3. Key Players of Dry AMD
Table 4. Global Age-related Macular Degeneration Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Age-related Macular Degeneration Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Age-related Macular Degeneration Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Age-related Macular Degeneration Market Share by Regions (2016-2021)
Table 8. Global Age-related Macular Degeneration Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Age-related Macular Degeneration Market Share by Regions (2022-2027)
Table 10. Age-related Macular Degeneration Market Trends
Table 11. Age-related Macular Degeneration Market Drivers
Table 12. Age-related Macular Degeneration Market Challenges
Table 13. Age-related Macular Degeneration Market Restraints
Table 14. Global Age-related Macular Degeneration Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Age-related Macular Degeneration Market Share by Players (2016-2021)
Table 16. Global Top Age-related Macular Degeneration Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age-related Macular Degeneration as of 2020)
Table 17. Ranking of Global Top Age-related Macular Degeneration Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Age-related Macular Degeneration Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Age-related Macular Degeneration Product Solution and Service
Table 21. Date of Enter into Age-related Macular Degeneration Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Age-related Macular Degeneration Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Age-related Macular Degeneration Revenue Market Share by Type (2016-2021)
Table 25. Global Age-related Macular Degeneration Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Age-related Macular Degeneration Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Age-related Macular Degeneration Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Age-related Macular Degeneration Revenue Market Share by Application (2016-2021)
Table 29. Global Age-related Macular Degeneration Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Age-related Macular Degeneration Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Age-related Macular Degeneration Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Age-related Macular Degeneration Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Age-related Macular Degeneration Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Age-related Macular Degeneration Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Age-related Macular Degeneration Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Age-related Macular Degeneration Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Age-related Macular Degeneration Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Age-related Macular Degeneration Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Age-related Macular Degeneration Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Age-related Macular Degeneration Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Age-related Macular Degeneration Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Age-related Macular Degeneration Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Age-related Macular Degeneration Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Age-related Macular Degeneration Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Age-related Macular Degeneration Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Age-related Macular Degeneration Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Age-related Macular Degeneration Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Age-related Macular Degeneration Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Age-related Macular Degeneration Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Age-related Macular Degeneration Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Age-related Macular Degeneration Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Age-related Macular Degeneration Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Age-related Macular Degeneration Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Age-related Macular Degeneration Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Age-related Macular Degeneration Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Age-related Macular Degeneration Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Age-related Macular Degeneration Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Age-related Macular Degeneration Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Age-related Macular Degeneration Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Age-related Macular Degeneration Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bayer HealthCare Company Details
Table 62. Bayer HealthCare Business Overview
Table 63. Bayer HealthCare Age-related Macular Degeneration Product
Table 64. Bayer HealthCare Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
Table 65. Bayer HealthCare Recent Development
Table 66. F. Hoffmann-La Roche Company Details
Table 67. F. Hoffmann-La Roche Business Overview
Table 68. F. Hoffmann-La Roche Age-related Macular Degeneration Product
Table 69. F. Hoffmann-La Roche Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
Table 70. F. Hoffmann-La Roche Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Age-related Macular Degeneration Product
Table 74. Novartis Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Regeneron Pharmaceuticals Company Details
Table 77. Regeneron Pharmaceuticals Business Overview
Table 78. Regeneron Pharmaceuticals Age-related Macular Degeneration Product
Table 79. Regeneron Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
Table 80. Regeneron Pharmaceuticals Recent Development
Table 81. Alcon Company Details
Table 82. Alcon Business Overview
Table 83. Alcon Age-related Macular Degeneration Product
Table 84. Alcon Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
Table 85. Alcon Recent Development
Table 86. Allergan Company Details
Table 87. Allergan Business Overview
Table 88. Allergan Age-related Macular Degeneration Product
Table 89. Allergan Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
Table 90. Allergan Recent Development
Table 91. Avalanche Company Details
Table 92. Avalanche Business Overview
Table 93. Avalanche Age-related Macular Degeneration Product
Table 94. Avalanche Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
Table 95. Avalanche Recent Development
Table 96. Bausch+Lomb Company Details
Table 97. Bausch+Lomb Business Overview
Table 98. Bausch+Lomb Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
Table 99. Bausch+Lomb Recent Development
Table 100. Gilead Sciences Company Details
Table 101. Gilead Sciences Business Overview
Table 102. Gilead Sciences Age-related Macular Degeneration Product
Table 103. Gilead Sciences Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
Table 104. Gilead Sciences Recent Development
Table 105. Iconic Therapeutics Company Details
Table 106. Iconic Therapeutics Business Overview
Table 107. Iconic Therapeutics Age-related Macular Degeneration Product
Table 108. Iconic Therapeutics Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
Table 109. Iconic Therapeutics Recent Development
Table 110. Neurotech Pharmaceuticals Company Details
Table 111. Neurotech Pharmaceuticals Business Overview
Table 112. Neurotech Pharmaceuticals Age-related Macular Degeneration Product
Table 113. Neurotech Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
Table 114. Neurotech Pharmaceuticals Recent Development
Table 115. Ohr Pharmaceutical Company Details
Table 116. Ohr Pharmaceutical Business Overview
Table 117. Ohr Pharmaceutical Age-related Macular Degeneration Product
Table 118. Ohr Pharmaceutical Revenue in Age-related Macular Degeneration Business (2016-2021) & (US$ Million)
Table 119. Ohr Pharmaceutical Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Age-related Macular Degeneration Market Share by Type: 2020 VS 2027
Figure 2. Wet AMD Features
Figure 3. Dry AMD Features
Figure 4. Global Age-related Macular Degeneration Market Share by Application: 2020 VS 2027
Figure 5. Drugstore Case Studies
Figure 6. Hospital Case Studies
Figure 7. Others Case Studies
Figure 8. Age-related Macular Degeneration Report Years Considered
Figure 9. Global Age-related Macular Degeneration Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Age-related Macular Degeneration Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Age-related Macular Degeneration Market Share by Regions: 2020 VS 2027
Figure 12. Global Age-related Macular Degeneration Market Share by Regions (2022-2027)
Figure 13. Global Age-related Macular Degeneration Market Share by Players in 2020
Figure 14. Global Top Age-related Macular Degeneration Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age-related Macular Degeneration as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Age-related Macular Degeneration Revenue in 2020
Figure 16. Global Age-related Macular Degeneration Revenue Market Share by Type (2016-2021)
Figure 17. Global Age-related Macular Degeneration Revenue Market Share by Type (2022-2027)
Figure 18. North America Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Age-related Macular Degeneration Market Share by Type (2016-2027)
Figure 20. North America Age-related Macular Degeneration Market Share by Application (2016-2027)
Figure 21. North America Age-related Macular Degeneration Market Share by Country (2016-2027)
Figure 22. United States Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Age-related Macular Degeneration Market Share by Type (2016-2027)
Figure 26. Europe Age-related Macular Degeneration Market Share by Application (2016-2027)
Figure 27. Europe Age-related Macular Degeneration Market Share by Country (2016-2027)
Figure 28. Germany Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Age-related Macular Degeneration Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Age-related Macular Degeneration Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Age-related Macular Degeneration Market Share by Region (2016-2027)
Figure 38. China Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Age-related Macular Degeneration Market Share by Type (2016-2027)
Figure 46. Latin America Age-related Macular Degeneration Market Share by Application (2016-2027)
Figure 47. Latin America Age-related Macular Degeneration Market Share by Country (2016-2027)
Figure 48. Mexico Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Age-related Macular Degeneration Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Age-related Macular Degeneration Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Age-related Macular Degeneration Market Share by Country (2016-2027)
Figure 54. Turkey Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Age-related Macular Degeneration Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Bayer HealthCare Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
Figure 60. Regeneron Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
Figure 61. Alcon Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
Figure 62. Allergan Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
Figure 63. Avalanche Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
Figure 64. Bausch+Lomb Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
Figure 65. Gilead Sciences Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
Figure 66. Iconic Therapeutics Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
Figure 67. Neurotech Pharmaceuticals Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
Figure 68. Ohr Pharmaceutical Revenue Growth Rate in Age-related Macular Degeneration Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
  • Global and United States Surgical Catheters Market Insights, Forecast to 2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 161
    Surgical Catheters market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Surgical Catheters market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Surgical Ca......
  • Global and Japan Surgical Smoke Aspirators Market Insights, Forecast to 2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 144
    Surgical Smoke Aspirators market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Surgical Smoke Aspirators market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Surgi......
  • Global and China Orthopedic Instruments Market Insights, Forecast to 2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 166
    Orthopedic Instruments market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Orthopedic Instruments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Orthopedic ......
  • Global and United States Nasal Cannulas Market Insights, Forecast to 2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 134
    Nasal Cannulas market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nasal Cannulas market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Nasal Cannulas mark......
  • Global and China Molecular Diagnostics Systems Market Insights, Forecast to 2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 149
    Molecular Diagnostics Systems market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on t......
  • Global and China LED Phototherapy System Market Insights, Forecast to 2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 146
    LED Phototherapy System market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global LED Phototherapy System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the LED Photo......
  • Global and United States Bone Marrow Aspiration and Biopsy Market Size, Status and Forecast 2021-2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 105
    Global Bone Marrow Aspiration and Biopsy Scope and Market Size Bone Marrow Aspiration and Biopsy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bone Marrow Aspiration and Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 201......
  • Global and China HDL Cholesterol Market Size, Status and Forecast 2021-2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 109
    Global HDL Cholesterol Scope and Market Size HDL Cholesterol market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global HDL Cholesterol market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type - Regent......
  • Global and United States Hepatitis B Testing Market Size, Status and Forecast 2021-2027
    Published: 24-Sep-2021        Price: US 3900 Onwards        Pages: 106
    Global Hepatitis B Testing Scope and Market Size Hepatitis B Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis B Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs